Cargando…
Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma
OBJECTIVE: The aim of the present study was to analyze the prognostic factors in patients with hepatoblastoma (HB) in our single center and to evaluate periostin (POSTN) expression in HB and its association with clinicopathological variables. In addition, the underlying mechanism of how POSTN promot...
Autores principales: | Chen, Lu, Tian, Xiangdong, Gong, Wenchen, Sun, Bo, Li, Guangtao, Liu, Dongming, Guo, Piao, He, Yuchao, Chen, Ziye, Xia, Yuren, Song, Tianqiang, Guo, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528457/ https://www.ncbi.nlm.nih.gov/pubmed/31119049 http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0077 |
Ejemplares similares
-
HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway
por: Chen, Lu, et al.
Publicado: (2018) -
Periostin promotes epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung cancer
por: Hu, Wei-Wei, et al.
Publicado: (2017) -
‘Teratoid’ Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma
por: Sergi, Consolato M., et al.
Publicado: (2022) -
Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update
por: Morra, Laura, et al.
Publicado: (2011) -
PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway
por: Han, Zhiqiang, et al.
Publicado: (2021)